My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 170

    1.

    Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.

    Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S.

    Breast Cancer Res. 2009;11(4):R59. Epub 2009 Aug 10.

    PMID:
    19664291
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

    Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen EN, Andreopoulou E, Hall CS, Lodhi A, Jackson S, Lucci A.

    Cancer. 2010 Jul 15;116(14):3330-7.

    PMID:
    20564098
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    3.

    Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.

    Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, Kontopodis E, Hatzidaki D, Mavroudis D, Georgoulias V.

    Br J Cancer. 2009 Aug 18;101(4):589-97. Epub 2009 Jul 21.

    PMID:
    19623181
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    4.

    ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.

    Fehm T, Krawczyk N, Solomayer EF, Becker-Pergola G, Dürr-Störzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S.

    Breast Cancer Res. 2008;10(5):R76. Epub 2008 Sep 15.

    PMID:
    18793387
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    5.

    Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.

    Yie SM, Luo B, Ye NY, Xie K, Ye SR.

    Clin Exp Metastasis. 2006;23(5-6):279-89. Epub 2006 Nov 3.

    PMID:
    17086357
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

    Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D.

    J Clin Oncol. 2007 Nov 20;25(33):5194-202. Epub 2007 Oct 22.

    PMID:
    17954712
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells.

    Schmitt M, Foekens JA.

    Breast Cancer Res. 2009;11(5):109. Epub .

    PMID:
    19833005
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    8.

    Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

    Aktas B, Müller V, Tewes M, Zeitz J, Kasimir-Bauer S, Loehberg CR, Rack B, Schneeweiss A, Fehm T.

    Gynecol Oncol. 2011 Aug;122(2):356-60. Epub 2011 May 24.

    PMID:
    21605893
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.

    Tewes M, Aktas B, Welt A, Mueller S, Hauch S, Kimmig R, Kasimir-Bauer S.

    Breast Cancer Res Treat. 2009 Jun;115(3):581-90. Epub 2008 Aug 5.

    PMID:
    18679793
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.

    Schindlbeck C, Stellwagen J, Jeschke U, Karsten U, Rack B, Janni W, Jückstock J, Tulusan A, Sommer H, Friese K.

    Clin Exp Metastasis. 2008;25(3):233-40. Epub 2008 Jan 10.

    PMID:
    18185913
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.

    Aktas B, Kasimir-Bauer S, Heubner M, Kimmig R, Wimberger P.

    Int J Gynecol Cancer. 2011 Jul;21(5):822-30.

    PMID:
    21613958
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.

    Slade MJ, Payne R, Riethdorf S, Ward B, Zaidi SA, Stebbing J, Palmieri C, Sinnett HD, Kulinskaya E, Pitfield T, McCormack RT, Pantel K, Coombes RC.

    Br J Cancer. 2009 Jan 13;100(1):160-6. Epub 2008 Nov 25.

    PMID:
    19034279
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    13.

    HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.

    Lang JE, Mosalpuria K, Cristofanilli M, Krishnamurthy S, Reuben J, Singh B, Bedrosian I, Meric-Bernstam F, Lucci A.

    Breast Cancer Res Treat. 2009 Feb;113(3):501-7. Epub 2008 Mar 9.

    PMID:
    18327638
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

    Fehm T, Müller V, Aktas B, Janni W, Schneeweiss A, Stickeler E, Lattrich C, Löhberg CR, Solomayer E, Rack B, Riethdorf S, Klein C, Schindlbeck C, Brocker K, Kasimir-Bauer S, Wallwiener D, Pantel K.

    Breast Cancer Res Treat. 2010 Nov;124(2):403-12. Epub 2010 Sep 22.

    PMID:
    20859679
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR.

    Berois N, Varangot M, Aizen B, Estrugo R, Zarantonelli L, Fernández P, Krygier G, Simonet F, Barrios E, Musé I, Osinaga E.

    Eur J Cancer. 2000 Apr;36(6):717-23.

    PMID:
    10762743
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

    Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S.

    Breast Cancer Res. 2009;11(4):R46. Epub 2009 Jul 9.

    PMID:
    19589136
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    17.

    Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.

    Fehm T, Becker S, Duerr-Stoerzer S, Sotlar K, Mueller V, Wallwiener D, Lane N, Solomayer E, Uhr J.

    Breast Cancer Res. 2007;9(5):R74.

    PMID:
    17963511
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    18.

    Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.

    Chen Y, Zou TN, Wu ZP, Zhou YC, Gu YL, Liu X, Jin CG, Wang XC.

    Int J Biol Markers. 2010 Apr-Jun;25(2):59-68.

    PMID:
    20586026
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.

    Apostolaki S, Perraki M, Pallis A, Bozionelou V, Agelaki S, Kanellou P, Kotsakis A, Politaki E, Kalbakis K, Kalykaki A, Vamvakas L, Georgoulias V, Mavroudis D.

    Ann Oncol. 2007 May;18(5):851-8. Epub 2007 Feb 14. Erratum in: Ann Oncol. 2007 Nov;18(11):1916.

    PMID:
    17301075
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    20.

    Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

    Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW.

    Tumori. 2010 Jan-Feb;96(1):103-10.

    PMID:
    20437866
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk